Three blogs centered around the top questions patients may have around probiotics.

In a new comment letter to FDA, AGA commends FDA’s recent draft guidance — “Policy Regarding Quantitative Labeling of Dietary Supplements Containing Live Microbials” — clarifying the expectations of probiotics manufacturers who choose to specify the amount of a live microbial component in their product in colony forming units (CFUs). Though manufacturers are not currently required […]

By Purna Kashyap, MBBS, scientific advisory board member, AGA Center for Gut Microbiome Research and Education   Probiotics are live microorganisms that, when given in sufficient amounts, are expected to confer a health benefit on the host. In general, probiotics have been shown to have beneficial effects on human health in a range of […]

Leading experts will address claims around probiotics and review the latest scientific evidence at the 2019 Gut Microbiota for Health World Summit. 

[…] from the probiotic product colonizing in the guts of some individuals but not others. These results were preliminary but exciting, and led to headlines ranging from “ Probiotics’ effects on the microbiome vary widely” to “Probiotics labeled ‘quite useless’.” Readers who did not continue past the headline could draw quite different conclusions depending on […]

Gail Hecht, MD, MS, AGAF, published a guest commentary in Healio Gastroenterology on probiotics.

[…] in diverse body sites, and non-food applications.4  The earliest prebiotic products were intended to increase colonic populations of Bifidobacterium and Lactobacillus5 — the first organisms designated “ probiotics” as defined by the World Health Organization (WHO).6 These bacteria produce strong acids (lactate and acetate), digestive enzymes, and cofactors, and displayed early evidence of immunomodulatory behavior.2 Initially, […]